Lentiviral reporter constructs for fluorescence tracking of the temporospatial pattern of Smad3 signaling

BioTechniques

Volumn 43, Issue 3, 2007, Pages 289-294

  Stuelten, Christina H ^a,b   Kamaraju, Anil K ^a   Wakefield, Lalage M ^a   Roberts, Anita B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; FLUORESCENCE; PATHOGENS; TUMORS;

METASTASIS; PATHOGENESIS; TEMPOROSPATIAL PATTERNS; WOUND HEALING;

PROTEINS;

GREEN FLUORESCENT PROTEIN; RED FLUORESCENT PROTEIN; SMAD3 PROTEIN; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; COCULTURE; CONTROLLED STUDY; GENE CONSTRUCT; HUMAN; HUMAN CELL; LENTIVIRINAE; METASTASIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REPORTER GENE; SIGNAL TRANSDUCTION;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; MICE; MICROSCOPY, FLUORESCENCE; PROMOTER REGIONS (GENETICS); SIGNAL TRANSDUCTION; SMAD3 PROTEIN; TRANSFECTION;

LENTIVIRUS;

EID: 34548683671     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112549     Document Type: Article

References (13)

1. Roberts, A.B., F. Tian, S.D. Byfield, C. Stuelten, A. Ooshima, S. Saika, and K.C. Flanders. 2006. Smad3 is key to TGF-beta-mediated epithelial-to-mesenchymal transition, fibrosis, tumor suppression and metastasis. Cytokine Growth Factor Rev. 17:19-27.
2. Massague, J. 2000. How cells read TGF-beta signals. Nat. Rev. Mol. Cell Biol. 1:169-178.
3. Wakefield, L.M. and A.B. Roberts. 2002. TGF-beta signaling: positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 12:22-29.
4. Kang, Y., W. He, S. Tulley, G.P. Gupta, I. Serganova, C.R. Chen, K. Manova-Todorova, R. Blasberg, et al. 2005. Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway. Proc. Natl. Acad. Sci. USA 102:13909-13914.
5. Xie, W., J.C. Mertens, D.J. Reiss, D.L. Rimm, R.L. Camp, B.G. Haffty, and M. Reiss. 2002. Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study. Cancer Res. 62:497-505.
6. Lin, A.H., J. Luo, L.H. Mondshein, P. ten Dijke, D. Vivien, C.H. Contag, and T. Wyss-Coray. 2005. Global analysis of Smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury. J. Immunol. 175:547-554.
7. Luo, J., A.H. Lin, E. Masliah, and T. Wyss-Coray. 2006. Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegeneration. Proc. Natl. Acad. Sci. USA 103:18326- 18331.
8. Roberts, A.B. and L.M. Wakefield. 2003. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 100:8621-8623.
9. Bierie, B. and H.L. Moses. 2006. TGF-beta and cancer. Cytokine Growth Factor Rev. 17:29-40.
10. Piek, E., U. Westermark, M. Kastemar, C.H. Heldin, E.J. van Zoelen, M. Nister, and P. ten Dijke. 1999. Expression of transforming-growth-factor (TGF)-beta receptors and Smad proteins in glioblastoma cell lines with distinct responses to TGF-beta1. Int. J. Cancer 80:756-763.
11. Piek, E., W.J. Ju, J. Heyer, D. Escalante-Alcalde, C.L. Stewart, M. Weinstein, C. Deng, R. Kucherlapati, et al. 2001. Functional characterization of transforming growth factor beta signaling in Smad2- and Smad3-deficient fibroblasts. J. Biol. Chem. 276:19945-19953.
12. Stuelten, C.H., S.D. Byfield, P.R. Arany, T.S. Karpova, W.G. Stetler-Stevenson, and A.B. Roberts. 2005. Breast cancer cells induce stromal fibroblasts to express MMP-9 via secretion of TNF-{alpha} and TGF-{beta}. J. Cell Sci. 118:2143-2153.
13. Tang, B., M. Vu, T. Booker, S.J. Santner, F.R. Miller, M.R. Anver, and L.M. Wakefield. 2003. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J. Clin. Invest. 112:1116-1124.